Literature DB >> 12614592

ET-1 contributes to age-dependent G protein impairment after brain injury.

William M Armstead1.   

Abstract

Previous studies have observed that endothelin-1 (ET-1) concentration is elevated in CSF and contributes to impaired cerebral hemodynamics following fluid percussion brain injury (FPI) in an age-dependent manner. This study was designed to characterize the effects of FPI on the vascular activity of two activators of a pertussin toxin-sensitive G protein, mastoparan and mastoparan-7, as a function of age and the role of ET-1 in such effects in newborn (1-5 days old) and juvenile (3-4 weeks old) pigs equipped with a closed cranial window. Mastoparan (10(-8), 10(-6) M) elicited pial artery dilation that was blunted more by FPI in newborn versus juvenile pigs (9 +/- 1 and 16 +/- 1 vs. 3 +/- 1 and 5 +/- 1%, newborn; 9 +/- 1 and 15 +/- 1 vs. 6 +/- 1 and 9 +/- 1%, juvenile). Similar results were observed for mastoparan-7, but the inactive analogue mastoparan-17 had no effect on pial diameter. BQ123 (10(-6) M), an ET-1 antagonist, partially restored impaired mastoparan dilation after FPI in the newborn but not in the juvenile (3 +/- 1 and 5 +/- 1 vs. 7 +/- 1 and 11 +/- 1%, newborn; 6 +/- 1 and 9 +/- 1 vs. 6 +/- 1 and 10 +/- 1%, juvenile). These data show that G protein activation elicits cerebrovasodilation that is blunted following FPI in an age-dependent manner. These data suggest that ET-1 contributes to the impairment of G protein-mediated vasodilation in an age-dependent manner after FPI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614592     DOI: 10.1089/08977150360517227

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  1 in total

1.  Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia.

Authors:  Bhavani P Thampatty; Paula R Sherwood; Matthew J Gallek; Elizabeth A Crago; Dianxu Ren; Allison J Hricik; Chien-Wen J Kuo; Megan M Klamerus; Sheila A Alexander; Catherine M Bender; Leslie A Hoffman; Michael B Horowitz; Amin B Kassam; Samuel M Poloyac
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.